000			02211 a2200625 4500
005			20250517023822.0
264		0	_c20160422
008			201604s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0119512 _2doi
040			_aNLM _beng _cNLM
100	1		_aTahtouh, Roula
245	0	0	_aTelomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study. _h[electronic resource]
260			_bPloS one _c2015
300			_ae0119512 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAminobenzoates _xpharmacology
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHep G2 Cells
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aNaphthalenes _xpharmacology
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRNA, Neoplasm _xgenetics
650	0	4	_aRNA, Small Interfering _xgenetics
650	0	4	_aSesquiterpenes _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTOR Serine-Threonine Kinases _xmetabolism
650	0	4	_aTelomerase _xantagonists & inhibitors
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aalpha-Fetoproteins _xgenetics
700	1		_aAzzi, Anne-Sophie
700	1		_aAlaaeddine, Nada
700	1		_aChamat, Soulaima
700	1		_aBouharoun-Tayoun, Hasnaa
700	1		_aWardi, Layal
700	1		_aRaad, Issam
700	1		_aSarkis, Riad
700	1		_aAntoun, Najibe Abou
700	1		_aHilal, George
773	0		_tPloS one _gvol. 10 _gno. 3 _gp. e0119512
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0119512 _zAvailable from publisher's website
999			_c24755463 _d24755463